"Closed-Loop Insulin System Boosts Pregnancy Safety for Women with Type 1 Diabetes"

A closed-loop insulin system significantly enhances pregnancy safety for women with type 1 diabetes, addressing critical hyperglycemia-related complications during pregnancy.

• An open-label trial involving 14 clinics assessed the efficacy of a closed-loop system for pregnant women with type 1 diabetes, focusing on improving Glucose control.
• The research highlights that hyperglycemia-related pregnancy complications affect 50% of women with type 1 diabetes, emphasizing the need for better Insulin management during pregnancy.
• Findings suggest that closed-loop insulin systems, previously tested outside of pregnancy, can effectively reduce complications, thereby improving maternal and fetal health outcomes.